AAAAAA
Results:
1-13
|
Results: 13
Authors:
PARRIS WCV
JOHNSON BW
CROGHAN MK
MOORE MR
KHOJASTEH A
REDER RF
KAIKO RF
BUCKLEY BJ
Citation: Wcv. Parris et al., THE USE OF CONTROLLED-RELEASE OXYCODONE FOR THE TREATMENT OF CHRONIC CANCER PAIN - A RANDOMIZED, DOUBLE-BLIND-STUDY, Journal of pain and symptom management, 16(4), 1998, pp. 205-211
Authors:
CITRON ML
KAPLAN R
PARRIS WCV
CROGHAN MK
HERBST LH
ROSENBLUTH RJ
REDER RF
SLAGLE NS
BUCKLEY BJ
KAIKO RF
Citation: Ml. Citron et al., LONG-TERM ADMINISTRATION OF CONTROLLED-RELEASE OXYCODONE TABLETS FOR THE TREATMENT OF CANCER PAIN, Cancer investigation, 16(8), 1998, pp. 562-571
Authors:
KAPLAN R
PARRIS WCV
CITRON ML
ZHUKOVSKY D
REDER RF
BUCKLEY BJ
KAIKO RF
Citation: R. Kaplan et al., COMPARISON OF CONTROLLED-RELEASE AND IMMEDIATE-RELEASE OXYCODONE TABLETS IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3230-3237
Authors:
KAIKO RF
Citation: Rf. Kaiko, THE EFFECT OF FOOD-INTAKE ON THE PHARMACOKINETICS OF SUSTAINED-RELEASE MORPHINE-SULFATE CAPSULES, Clinical therapeutics, 19(2), 1997, pp. 296-303
Authors:
KAIKO RF
Citation: Rf. Kaiko, PHARMACOKINETICS AND PHARMACODYNAMICS OF CONTROLLED-RELEASE OPIOIDS, Acta anaesthesiologica Scandinavica, 41(1), 1997, pp. 166-174
Authors:
MANDEMA JW
KAIKO RF
OSHLACK B
REDER RF
STANSKI DR
Citation: Jw. Mandema et al., CHARACTERIZATION AND VALIDATION OF A PHARMACOKINETIC MODEL FOR CONTROLLED-RELEASE OXYCODONE, British journal of clinical pharmacology, 42(6), 1996, pp. 747-756
Authors:
REDER RF
OSHLACK B
MIOTTO JB
BENZIGER DD
KAIKO RF
Citation: Rf. Reder et al., STEADY-STATE BIOAVAILABILITY OF CONTROLLED-RELEASE OXYCODONE IN NORMAL SUBJECTS, Clinical therapeutics, 18(1), 1996, pp. 95-105
Authors:
SUNSHINE A
OLSON NZ
COLON A
RIVERA J
KAIKO RF
FITZMARTIN RD
REDER RF
GOLDENHEIM PD
Citation: A. Sunshine et al., ANALGESIC EFFICACY OF CONTROLLED-RELEASE OXYCODONE IN POSTOPERATIVE PAIN, Journal of clinical pharmacology, 36(7), 1996, pp. 595-603
Authors:
BENZIGER DP
KAIKO RF
MIOTTO JB
FITZMARTIN RD
REDER RF
CHASIN M
Citation: Dp. Benziger et al., DIFFERENTIAL-EFFECTS OF FOOD ON THE BIOAVAILABILITY OF CONTROLLED-RELEASE OXYCODONE TABLETS AND IMMEDIATE-RELEASE OXYCODONE SOLUTION, Journal of pharmaceutical sciences, 85(4), 1996, pp. 407-410
Authors:
KAIKO RF
BENZIGER DP
FITZMARTIN RD
BURKE BE
REDER RF
GOLDENHEIM PD
Citation: Rf. Kaiko et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF CONTROLLED-RELEASE OXYCODONE, Clinical pharmacology and therapeutics, 59(1), 1996, pp. 52-61
Authors:
BASHAW ED
KAIKO RF
GRANDY RP
REDER RF
GOLDENHEIM PD
Citation: Ed. Bashaw et al., RELATIVE BIOAVAILABILITY OF CONTROLLED-RELEASE ORAL MORPHINE-SULFATE DURING NALTREXONE BLOCKADE, International journal of clinical pharmacology and therapeutics, 33(9), 1995, pp. 524-529
Authors:
KAIKO RF
GRANDY RP
REDER RF
GOLDENHEIM PD
SACKLER RS
Citation: Rf. Kaiko et al., A BIOEQUIVALENCE STUDY OF ORAL CONTROLLED-RELEASE MORPHINE USING NALTREXONE BLOCKADE, Journal of clinical pharmacology, 35(5), 1995, pp. 499-504
Authors:
BLOOMFIELD SS
CISSELL GB
MITCHELL J
BARDEN TP
KAIKO RF
FITZMARTIN RD
GRANDY RP
KOMOROWSKI J
GOLDENHEIM PD
Citation: Ss. Bloomfield et al., ANALGESIC EFFICACY AND POTENCY OF 2 ORAL CONTROLLED-RELEASE MORPHINE PREPARATIONS, Clinical pharmacology and therapeutics, 53(4), 1993, pp. 469-478
Risultati:
1-13
|